Novartis AG Sponsored ADR (NVS) - Financials, balance sheet (quarterly)

118.019997 USD

0.23

0.20%

Last update Jun 6, 3:59 PM EDT

Market closed

Day range

118.019997

117.24000

118.46000

Previous close

117.79000

Open

117.24000

Access this stock data via API

Novartis AG Sponsored ADR

118.02

0.23

0.20%

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	99.9B	102.2B	103.5B	97.5B
Current assets	25.1B	29.7B	31.3B	25.7B
Cash	—	2.6B	—	—
Cash equivalents	—	8.9B	—	—
Cash and cash equivalents	7.1B	11.5B	13.6B	7.9B
Other short term investments	130M	1.9B	411M	532M
Accounts receivable	8.6B	7.4B	8.0B	8.2B
Other receivables	—	1.4B	—	—
Inventory	5.8B	5.7B	5.9B	5.7B
Prepaid assets	—	985M	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	106M	—	—
Other current assets	3.4B	—	3.2B	3.0B
Non current assets	74.8B	72.5B	72.3B	71.8B
Properties	11.1B	58M	11.2B	10.6B
Land and improvements	—	848M	—	—
Machinery furniture equipment	—	9.2B	—	—
Construction in progress	—	1.6B	—	—
Leases	—	—	—	—
Accumulated depreciation	—	-11.1B	—	—
Goodwill	77.4B	76.4B	77.8B	78.2B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	27.5B	26.9B	27.9B	27.8B
Investments and advances	2.1B	1.1B	2.2B	2.1B
Other non current assets	9.2B	6.2B	6.0B	6.1B
Total liabilities	61.5B	58.1B	60.1B	55.6B
Current liabilities	31.6B	28.7B	28.1B	27.6B
Accounts payable	4.3B	4.6B	4.1B	4.1B
Accrued expenses	—	2.2B	—	—
Short term debt	8.0B	8.3B	6.8B	7.8B
Deferred revenue	—	127M	—	—
Tax payable	2.6B	2.2B	2.2B	1.9B
Pensions	—	2.4B	—	—
Other current liabilities	16.7B	424M	15.1B	13.8B
Non current liabilities	29.9B	29.4B	32.0B	28.0B
Long term provisions	—	561M	—	—
Long term debt	23.2B	22.9B	25.3B	21.2B
Provision for risks and charges	—	—	—	—
Deferred liabilities	2.5B	2.4B	2.2B	2.5B
Derivative product liabilities	—	—	—	—
Other non current liabilities	4.1B	1.0B	4.4B	4.3B
Shareholders equity
Common stock	766M	793M	793M	793M
Retained earnings	39.8B	46.6B	46.3B	45.8B
Other shareholders equity	-2.2B	-3.3B	-3.7B	-4.9B
Total shareholders equity	38.5B	44.1B	43.4B	41.9B
Additional paid in capital	—	—	—	—
Treasury stock	19M	53M	40M	25M
Minority interest	83M	80M	124M	169M